PROGRAM
| 8:30 - 9:00 AM | Registration & Coffee: LKS, 2nd floor lobby |
| 9:00 - 9:05 AM | Opening Remarks |
| 9:05 - 9:50 AM | Keynote Address Howard Chang Chief Scientific Officer and SVP Global Research, Amgen |
| Session I: |
Induced Proximity and Next-Generation Modalities |
| 9:50 - 10:25 AM | Neil Bence Senior Vice President, Bristol Myers Squibb |
| 10:25 - 11:00 AM | Phil Chamberlain Chief Executive Officer, Neomorph |
| 11:00 - 11:20 AM | Coffee Break |
| 11:20 - 11:55 AM | Andrew Phillips Senior Director, AbbVie |
| Session II: |
Engineering Therapies for the Nervous System |
| 11:55 - 12:30 PM | Marina Bershteyn Senior Director, Neurona Therapeutics |
| 12:30- 1:05 PM | Shilpa Sambashivan Chief Executive Officer, Nura Bio |
| 1:05 - 2:15 PM | Lunch |
| 2:15 - 2:50 PM | Kevin Eggan Chief Scientific Officer, BioMarin |
| 2:50 - 3:25 PM | MTx Faculty Talk Daniel Nomura Professor of Molecular Therapeutics |
| Session III: |
Scaling Up Approaches to Drug Discovery |
| 3:25 - 4:00 PM | Matthew Albert VP, Discovery Biology, Octant Bio |
| 4:00 - 4:35 PM | Leena Patel Senior Director, Gilead Sciences |
| 4:35 - 4:45 PM | Break & Poster Setup |
| 4:45 - 7:30 PM | Poster Session, Networking, and Reception Featuring posters from students, postdocs, and participating companies |